Saratov City Clinical Hospital № 2 named. IN AND. Razumovsky

Recent papers from Saratov City Clinical Hospital № 2 named. IN AND. Razumovsky

1. The health care system and its sub-systems — medical organizations: interaction with external actors (the review)Problems of Social Hygiene Public Health and History of Medicine · 2026
2. The influence of socio-psychological factors, adverse effects of hormone therapy on the refusal of patients from its implementation or interruption of therapy after surgical treatment of ovarian endometriosisRussian Bulletin of Obstetrician-Gynecologist · 2026
3. Polymorbidity and interaction between the participants of the diagnostics and treatment process (on the example of urolithiasis)Медицинский вестник МВД · 2026
4. Quality of life of pregnant women associated with prenatal risk of complicated course of pregnancyNational Health Care (Russia) · 2025
5. Clinical observations of elderly patients with dyspnea in the late post-COVID-19 periodMeditsinskiy sovet = Medical Council · 2025
6. The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTADoklady Biochemistry and Biophysics · 2025
7. The Efficacy and Safety of Divozilimab in Patient with Systemic Sclerosis: 48-Week Results of the Randomized Double-Blind Placebo-Controlled Phase III Clinical Study LIBERIUSDoklady Biochemistry and Biophysics · 2025
8. Modern methods of treatment of patients with varicose veins of the lower extremities: History, myths and realityAmbulatornaya khirurgiya = Ambulatory Surgery (Russia) · 2024
9. RISK FACTORS FOR REPEATED DISORDERS OF CEREBRAL CIRCULATION (Review of literature)Медицинский вестник МВД · 2024
10. Outcomes of Placental Abruption Depending on Severity of Pre-Eclampsia: A Multicentre Cohort Observational Retrospective StudyFundamental and Clinical Medicine · 2024
11. Effectiveness and safety of BCD180, anti-TRBV9⁺ T-lymphocytes monoclonal antibody in patients with active radiographic axial spondyloarthritis: 36-week results of double-blind randomized placebo-controlled phase II clinical study ELEFTARheumatology Science and Practice · 2024
12. Long-term efficacy and safety of netakimab in patients with active ankylosing spondylitis: results of three years of use in the international multicentre, randomized, double-blind, phase III clinical trial BCD-085-5/ASTERAModern Rheumatology Journal · 2024
13. Long-term effects of netakimab on health-related quality of life, back pain and work productivity in patients with ankylosing spondylitis: results of the international, multicentre, randomized double-blind phase III clinical trial BCD-085-5/ASTERAModern Rheumatology Journal · 2023
14. NaYF4: Yb,Er Upconversion Nanoparticles for Imaging: Effect on Red Blood CellsPhotonics · 2023
15. Idiopathic Harlequin syndrome.Russian neurological Journal · 2023
16. Multimodal Diagnostics of Changes in Rat Lungs after VapingDiagnostics · 2023
17. Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multicenter randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER)BMJ Open Diabetes Research & Care · 2022
18. Are anthropometric data a tool for determining the severity of OHSS? Yes, it could be!BMC Women s Health · 2022
19. A Novel Method to Stimulate Lymphatic Clearance of Beta-Amyloid from Mouse Brain Using Noninvasive Music-Induced Opening of the Blood–Brain Barrier with EEG MarkersApplied Sciences · 2021
20. A Novel Method to Stimulate Lymphatic Clearance of Beta-Amyloid from Mouse Brain Using Non-invasive Music-Induced Opening of the Blood-Brain Barrier with EEG Markers2021